Literature DB >> 12405287

Transduction of HOXD3-antisense into human melanoma cells results in decreased invasive and motile activities.

Yoshiko Okubo1, Jun-ichi Hamada, Yoko Takahashi, Mitsuhiro Tada, Arata Tsutsumida, Keiji Furuuchi, Tetsuya Aoyama, Tsuneki Sugihara, Tetsuya Moriuchi.   

Abstract

Homeobox genes regulate sets of genes that determine cellular fates in embryonic morphogenesis and maintenance of adult tissue architecture by regulating cellular motility and cell-cell interactions. Our previous studies showed that a specific member, HOXD3, when overexpressed, enhanced cell motility and invasiveness of human lung cancer A549 cells (Hamada et al. Int. J. Cancer 2001; 93: 516-25 [19]). In the present study, we investigated the roles of HOXD3 in motile and invasive behavior of human malignant melanoma cells. Of seven melanoma cell lines examined here, six cell lines expressed the HOXD3 gene, whereas normal melanocytes did not. We transduced the HOXD3-antisense gene expression vector into two cell lines (A375M and MMIV). The cell transduced with the HOXD3-antisense gene showed reduced in vitro invasion of Matrigel. The transduction of the HOXD3-antisense gene also decreased cell spreading, haptotactic activity to vitronectin and laminin-1, and phagokinetic activity. To find the difference of gene expression between the HOXD3-antisense-transduced A375M cells and the control A375MNeo2 cells, we carried out cDNA microarray analysis. The results of the microarray analysis indicated that the increased expression of cdc42-interacting protein 4, KIAA0554 and tropomyosin 1, which are all associated with the cytoskeletal system, may be involved in the reduction of motile and invasive activity by the HOXD3-antisense gene transduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12405287     DOI: 10.1023/a:1020346211686

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  30 in total

1.  A cDNA encoding a muscle-type tropomyosin cloned from a human epithelial cell line: identity with human fibroblast tropomyosin TM1.

Authors:  G L Prasad; S Meissner; D G Sheer; H L Cooper
Journal:  Biochem Biophys Res Commun       Date:  1991-06-28       Impact factor: 3.575

2.  A Cdc42 target protein with homology to the non-kinase domain of FER has a potential role in regulating the actin cytoskeleton.

Authors:  P Aspenström
Journal:  Curr Biol       Date:  1997-07-01       Impact factor: 10.834

Review 3.  Homeobox genes and cancer.

Authors:  C Cillo; A Faiella; M Cantile; E Boncinelli
Journal:  Exp Cell Res       Date:  1999-04-10       Impact factor: 3.905

Review 4.  Regulation of vertebrate homeobox-containing genes by morphogens.

Authors:  F Mavilio
Journal:  Eur J Biochem       Date:  1993-03-01

5.  Altered HOX and WNT7A expression in human lung cancer.

Authors:  R Calvo; J West; W Franklin; P Erickson; L Bemis; E Li; B Helfrich; P Bunn; J Roche; E Brambilla; R Rosell; R M Gemmill; H A Drabkin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

6.  HOX gene expression in normal and neoplastic human kidney.

Authors:  C Cillo; P Barba; G Freschi; G Bucciarelli; M C Magli; E Boncinelli
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

7.  HOX gene expression in human small-cell lung cancers xenografted into nude mice.

Authors:  C Tiberio; P Barba; M C Magli; F Arvelo; T Le Chevalier; M F Poupon; C Cillo
Journal:  Int J Cancer       Date:  1994-08-15       Impact factor: 7.396

8.  Overexpression of the HOX4A (HOXD3) homeobox gene in human erythroleukemia HEL cells results in altered adhesive properties.

Authors:  Y Taniguchi; N Komatsu; T Moriuchi
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

9.  Induction of the angiogenic phenotype by Hox D3.

Authors:  N Boudreau; C Andrews; A Srebrow; A Ravanpay; D A Cheresh
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

View more
  8 in total

Review 1.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

Review 2.  Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability.

Authors:  Leon P Bignold
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

3.  A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

Authors:  Ellen L Goode; Georgia Chenevix-Trench; Honglin Song; Susan J Ramus; Maria Notaridou; Kate Lawrenson; Martin Widschwendter; Robert A Vierkant; Melissa C Larson; Susanne K Kjaer; Michael J Birrer; Andrew Berchuck; Joellen Schildkraut; Ian Tomlinson; Lambertus A Kiemeney; Linda S Cook; Jacek Gronwald; Montserrat Garcia-Closas; Martin E Gore; Ian Campbell; Alice S Whittemore; Rebecca Sutphen; Catherine Phelan; Hoda Anton-Culver; Celeste Leigh Pearce; Diether Lambrechts; Mary Anne Rossing; Jenny Chang-Claude; Kirsten B Moysich; Marc T Goodman; Thilo Dörk; Heli Nevanlinna; Roberta B Ness; Thorunn Rafnar; Claus Hogdall; Estrid Hogdall; Brooke L Fridley; Julie M Cunningham; Weiva Sieh; Valerie McGuire; Andrew K Godwin; Daniel W Cramer; Dena Hernandez; Douglas Levine; Karen Lu; Edwin S Iversen; Rachel T Palmieri; Richard Houlston; Anne M van Altena; Katja K H Aben; Leon F A G Massuger; Angela Brooks-Wilson; Linda E Kelemen; Nhu D Le; Anna Jakubowska; Jan Lubinski; Krzysztof Medrek; Anne Stafford; Douglas F Easton; Jonathan Tyrer; Kelly L Bolton; Patricia Harrington; Diana Eccles; Ann Chen; Ashley N Molina; Barbara N Davila; Hector Arango; Ya-Yu Tsai; Zhihua Chen; Harvey A Risch; John McLaughlin; Steven A Narod; Argyrios Ziogas; Wendy Brewster; Aleksandra Gentry-Maharaj; Usha Menon; Anna H Wu; Daniel O Stram; Malcolm C Pike; Jonathan Beesley; Penelope M Webb; Xiaoqing Chen; Arif B Ekici; Falk C Thiel; Matthias W Beckmann; Hannah Yang; Nicolas Wentzensen; Jolanta Lissowska; Peter A Fasching; Evelyn Despierre; Frederic Amant; Ignace Vergote; Jennifer Doherty; Rebecca Hein; Shan Wang-Gohrke; Galina Lurie; Michael E Carney; Pamela J Thompson; Ingo Runnebaum; Peter Hillemanns; Matthias Dürst; Natalia Antonenkova; Natalia Bogdanova; Arto Leminen; Ralf Butzow; Tuomas Heikkinen; Kari Stefansson; Patrick Sulem; Sören Besenbacher; Thomas A Sellers; Simon A Gayther; Paul D P Pharoah
Journal:  Nat Genet       Date:  2010-09-19       Impact factor: 38.330

Review 4.  MiR-21: an environmental driver of malignant melanoma?

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2015-06-27       Impact factor: 5.531

5.  Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsies.

Authors:  Leonard N Chen; Rachel S Rubin; Eugide Othepa; Caroline Cer; Elizabeth Yun; Raghunath P Agarwal; Brian T Collins; Kevin McGeagh; John Pahira; Guarav Bandi; Keith Kowalczyk; Deepak Kumar; Anatoly Dritschilo; Sean P Collins; David G Bostwick; John H Lynch; Simeng Suy
Journal:  Prostate       Date:  2014-05       Impact factor: 4.104

6.  EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.

Authors:  Lumin Wang; Hongfei Sun; Xiaofei Wang; Ni Hou; Lingyu Zhao; Dongdong Tong; Kang He; Yang Yang; Tusheng Song; Jun Yang; Chen Huang
Journal:  Oncotarget       Date:  2016-07-19

7.  Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.

Authors:  Ken Kron; Vaijayanti Pethe; Laurent Briollais; Bekim Sadikovic; Hilmi Ozcelik; Alia Sunderji; Vasundara Venkateswaran; Jehonathan Pinthus; Neil Fleshner; Theodorus van der Kwast; Bharati Bapat
Journal:  PLoS One       Date:  2009-03-13       Impact factor: 3.240

8.  HOX Gene Aberrant Expression in Skin Melanoma: A Review.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont
Journal:  J Skin Cancer       Date:  2012-10-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.